Should You Buy Canopy Growth Stock on the Rebound?

Published September 5, 2026 · Category: Finance

Overview

Canopy Growth (NASDAQ: CGC) started trading publicly in Canada in 2014 via a reverse merger (then known as Tweed). It eventually got a listing in the United States in 2018, becoming one of the first U.S.-traded marijuana companies. The stock rocketed higher as investors jumped into the sector, expecting growth to be driven by the legalization of marijuana in more and more regions.

But Wall Street has a habit of getting too excited about hot investment ideas. The marijuana sector's growth didn't live up to expectations, and investors went from exuberance to despair. Today, Canopy Growth is a penny stock. But the first quarter of fiscal 2027 actually showed broad business improvement. Is the business rebound worth buying into?

Image source: Getty Images.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

• Plastic surgery is booming with boomers. Here’s how to cash in on the antiaging craze.
• This enhanced geothermal project aims to unlock gigawatts of power to fuel the data center boom
• With HSAs, employers are turning to the 401(k) playbook